CGEM stock

Cullinan Oncology LLC (CGEM) earnings · $830.3M cap

These earnings events as JSON? API free 100/day

Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.

This CGEM earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.

Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $111.2M. CGEM currently screens at market cap $830.3M.

When the next CGEM 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.

Period-over-period revenue change is not in cache for CGEM. We will not invent a beat or miss.

Not investment advice. Full CGEM research stays on the stock page; the tape stays on the quote page.

CGEM earnings FAQ

What is CGEM's latest net income?

Latest cached Cullinan Oncology LLC (CGEM) net income was $111.2M. Statements: https://lician.com/financials/cgem

What is CGEM's latest diluted EPS?

Latest cached Cullinan Oncology LLC (CGEM) diluted EPS for Dec 31, 2022 was $2.38.

What period does the latest CGEM earnings print cover?

The latest cached Cullinan Oncology LLC (CGEM) earnings print covers Dec 31, 2022.

Where are CGEM earnings listed?

Cached earnings facts for Cullinan Oncology LLC (CGEM) are listed at https://lician.com/earnings/cgem. Statements: https://lician.com/financials/cgem

Not investment advice.

Full CGEM analysis